UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.

Australia's drug approval system is under fire, with critics in the United States claiming it is too slow to approve ...

The Reserve Bank of Australia has named the fintechs and banks participating in a series of digital money and crypto asset trials later this year under Project Acacia, which has received regulatory ...

In a more challenging regulatory environment for clinical trials, optimising trial designs early makes success more likely.

Outdated regulations and inflexible sponsor processes are hampering clinical trial recruitment, but empowering sites with ...

Nar Hari Singh As neurotechnology enters Indian homes and workplaces, the law faces a mind-bending challenge: how do we ...

New Zealand is one of the best places in the world to grow dope, but producing marketable medicinal cannabis is a regulatory ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

The EU’s health commissioner says there’s “no time to lose” as he lays out a raft of plans in the Life Sciences Strategy for ...

Chia seeds vs. Flaxseeds: Which superfood is truly better for you?

Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next ...

Responding to the European Commission’s call for evidence, Biovia says regulatory delays, fragmented markets, and lack of ...